Peer Review History
| Original SubmissionFebruary 19, 2024 |
|---|
|
PONE-D-24-04536Psycho-oncology practice for cancer patients during the pandemic lockdown: a qualitative mixed-method study with Italian psychotherapistsPLOS ONE Dear Dr. PERIN, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 28 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Jan Christopher Cwik, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In the online submission form, you indicated that [All relevant data are within the manuscript and its Supporting Information files. The data supporting this study's findings are available from the corresponding author upon reasonable request.]. All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 3. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. 4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: [Response below is found in attachment as well] Thank you for giving me the opportunity to review this manuscript about this pivoting time in psycho-oncology history. The article was well-written and multi-layered. There were many relevant aspects that had important potential in terms of exploring the role and importance of psychotherapy within hospital settings. Within the abstract, I suggest you change “the final dataset included 102 valid questionnaires” to “the final dataset included 102 valid responses”. The introduction is clear although may be unnecessarily lengthy. I suggest that lines 65 to 81 be shortened to a sentence or two as I don’t think it is relevant to your research question. In addition, on lines 101-104 you mention that your article’s overarching goal is to promote psycho-oncology program. It is unclear to me in what ways this article will achieve this. Although I agree that your article advocates for more recognition of psycho-oncology professionals within hospital settings, have you thought about the ways in which you will disseminate your findings to stakeholders and policy makers within these hospital settings? Implementation science is the next big thing; how will your research contribute to the implementation of psycho-oncology care? Finally, should you have space, it may be important to further introduce/explain/breakdown what CIT is. The methods are generally clear and straightforward. However, as mentioned above, it may be relevant to provide further explanations as to your used of CIT. I suggest you also provide more information on your use of triangulation. It may be worth, for reproducibility, to provide more details on how this “framework” was used/built. Finally, it is unclear to me why you asked your participants about previous involvement in emergency psychology. How does that impact their answers to your questions? In what ways is this important to keep in mind? Finally, it may be important to clarify that this is an inpatient setting, right from the beginning, as the situation may be vastly different in outpatient settings. The results are well outlined, and themes appear clear and distinct. I suggest making theme 1 more explicit in the ways it relates to PTs’ practice and how they adapted. It appears to me that it is more strongly related to patients’ experience rather than PTs’ and therefore does not add much to your research question. In addition, the disclosure from patients could be further explained. How is this different than existential dread when facing potential death? Finally, the discussion really ties it all together. I appreciated the clearer distinction between your two bigger themes: innovation and lack of recognition. I believe both have great potential but are too tangled in your results. I suggest taking this distinction which you have mastered in the discussion and applying it to the rest of the article. In addition, most themes seem to be rooted in systemic issues and situational factors. Can you further discuss the recognition of psychotherapy in hospitals using a public health or systemic lens? What do those results mean, what changes are needed? You may not need to spend as much time on ICTs. Overall, this article addresses some important issues within psycho-oncology and sheds some light on its in hospital settings. Thank you for your submission. Reviewer #2: Thank you for the opportunity to review your manuscript. The topic you explore is highly relevant, especially given the challenges introduced by the COVID-19 pandemic in psychological support practices within oncology. Below, I provide a detailed review of your manuscript along with several suggestions to further strengthen it. General Comments The manuscript is well-written and addresses a timely and important topic. The use of a mixed-methods approach is appropriate for answering your research question. However, there are a few methodological and conceptual aspects that could be expanded to improve the transparency and clarity of the work. 1. Title and Abstract -The title is clear and descriptive, but I recommend specifying the geographic context (Italy) to make the focus on Italian psychotherapists more explicit for an international audience. -The abstract is clear, but the methodology section could be expanded, particularly to explain the "QUAL→qual mixed-method" approach for readers unfamiliar with this terminology. 2. Introduction -The introduction provides a comprehensive background on psycho-oncology and the implications of the pandemic. The reference to the history of psycho-oncology in Italy is well done. -Provide a clearer statement of the research gap early in the introduction. -Better explain the rationale for focusing on the Italian setting by relating it to international contexts, which could make the study’s findings more broadly applicable. 3. Methods -The mixed-methods approach (QUAL→qual) is appropriate, but more details are needed about how the qualitative data were triangulated and what criteria were used for selecting participants for the interviews. -Convenience sampling is acknowledged as a limitation, but the manuscript would benefit from a more in-depth discussion of how this might affect the generalizability of the findings. -Provide more information about the coding process, such as how discrepancies between coders were resolved. Clarify whether any measures were taken to ensure that the interview sample was representative of the broader survey population. 4. Results -The four main themes (patient relationships, clinical practice management, emotional aspects, and organizational aspects) are well supported by participant quotes, but the results section would benefit from clearer separation between survey and interview data. Reorganize the results section to explicitly separate the findings from the survey and interview phases before integrating them in the discussion. -Some subthemes, such as “the inner world of the psychotherapists,” are more abstract and would benefit from further elaboration or concrete examples. 5. Discussion -The discussion reflects thoughtfully on the challenges psychotherapists faced during the pandemic and effectively ties the findings to existing literature. -The discussion could benefit from a more critical evaluation of the study’s limitations, especially concerning the convenience sampling and the lack of representation from psychotherapists working with pediatric patients. Expand the discussion with a more detailed analysis of how these limitations might have influenced the results and their generalizability. -The points on the importance of ICT tools and staff support programs are well made, but the discussion could offer more concrete recommendations for policy and practice, particularly concerning how psycho-oncology services should prepare for future crises. 6. Conclusion -The conclusion effectively summarizes the key contributions of the study, particularly the value of ICT tools and the need for ongoing support for psycho-oncology services. Provide more actionable recommendations on how your findings can inform clinical practice or health policy. This would help bridge the gap between research and practice. 7. Ethical Considerations -Ethical approval is well described, and the consent process is clear. However, it would be helpful to briefly address any challenges related to ensuring confidentiality during remote interviews, given the sensitive nature of the topic. 8. Figures and Tables -The figures and tables are well-organized and informative. Table 2 is particularly helpful in contextualizing the sample. Consider adding more detail to Figure 1 (Mixed-methods design process) to clarify how the different phases of the study were integrated in the analysis. -Include thematic maps to better visualize the relationships between the different themes and subthemes. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Psycho-oncology practice for cancer patients during the pandemic lockdown in Italy: a qualitative mixed-method study with psychotherapists PONE-D-24-04536R1 Dear Dr. PERIN, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Jan Christopher Cwik, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: Dear Authors, Thank you for addressing the comments and suggestions provided in the previous round of reviews. I have carefully evaluated the revised manuscript and the changes you implemented. Overall, the revisions significantly improve the manuscript, addressing most of the concerns raised in the initial review. I believe the study is now a valuable contribution to the literature on psycho-oncology and pandemic-related healthcare challenges. Thank you for your thoughtful revisions and for engaging constructively with the feedback provided. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-24-04536R1 PLOS ONE Dear Dr. Perin, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Jan Christopher Cwik Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .